NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of CtDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Felicia Williams Joins NeoGenomics Board of Directors
Express News | Felicia Williams Joins Neogenomics Board of Directors
Earnings Scheduled For November 14, 2024